EP1210951 - Bibliographic data

Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone

Last update 05/05/2025
Legal status Brevet déchu
Origin Européen

(73) Holder

PFIZER PRODUCTS INC.

Eastern Point Road
Groton, CT 06340
États-Unis d'Amérique
(72) Inventors

McLean, David Burton, c/o Pfizer Global Res.& Dev.

Eastern Point Road
Groton, Connecticut 06340
États-Unis d'Amérique
(74) Agent

Mail recipient

Cabinet

José CURAU

17, rue Basse
98000
MONACO
Principauté de Monaco

(21) Request number EP01309457.8
(22) Request date 08/11/2001

(11) Publication number EP1210951
Publication date 02/02/2005

(54) Title of the invention Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone
(51) International classification None
International classification (before reform)

Claimed priority

(31) Number: 250071 P
(32) Date: 30/11/2000
(33) Country: US

Initial application None
Divisional application None

Expected annuity Annuity: 6 - Amount: 70 € - Due date 30/11/2006
Surtax: 6 - Amount: 14 € - Due date 31/05/2007
Last annuity Annuity: 5 - Payment date 14/02/2005

Publication

BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2005/1, of 31/03/2005

History

Publication de la délivrance du brevet européen - Legal date 02/02/2005


Déchéance du brevet d'invention après période de grâce - Legal date 30/11/2006


Entrée en période de grâce du brevet d'invention - Legal date 30/11/2006